MedTrace Logo

Sleep in Pediatric Intensive Care Patients

NCT05432076 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2023-01-13

No results posted yet for this study

Summary

This research will be carried out experimentally in order to investigate the Effect of Sleep Band and White Noise Use on the Time to Sleep in Pediatric Intensive Care Patients aged 3-12 months. The research will be carried out in Adana Province Seyhan State Hospital Pediatric Intensive Care Unit. The data obtained by creating experimental and control groups will be calculated. "Baby Information Form, Baby Sleep Problems Diagnosis Form, Baby Sleep Observation Form and Vital Findings Follow-up Chart" will be used to collect research data. In the study, sleep bands and white noise will be used for sleep for the babies in the experimental group, while the control group will not be interfered with. Ethics committee, institutional permission and informed consent from the parents of the infants will be obtained for the conduct of the study. SPSS demo package program will be used in data analysis. Examining the Effect Effect of Sleep Band and White Noise Use on Transition Time to Sleep in Pediatric Intensive Care Patients aged 3-12 months

, sleep ecology , sleep diagnostics Patients aged 3-12 months At the end of the research, it will be examined whether there is a difference between the sleep time, waking frequency and total sleep time of the babies in the experimental group using the sleep band and white noise, and the babies in the control group.

Conditions

  • Sleep

Interventions

DEVICE

Sleep Band and White Noise

Not taking any sedative or anesthetic drug in the last 12 hours (Such duration of action) An average of 12 hours of sleepiness at the patient's departure and travel hindrance will.) * Being extubated * A Glasgow coma scale of 15 (to be investigated by the Glasgow coma scale). * Baby dreams of boredom * Besides pain (to the "Wong Baker Face Scale" used in the Pediatric Intensive Care Unit) evaluation).

Sponsors & Collaborators

  • Ebru Kilic

    lead OTHER

Principal Investigators

  • Şenay Çetinkaya · Cukurova University

Eligibility

Min Age
3 Months
Max Age
12 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-21
Primary Completion
2023-01-11
Completion
2023-01-11

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05432076 on ClinicalTrials.gov